ArticleProteomics2025
OmixLitMiner 2: Guided Literature Mining for Automated Categorization of Marker Candidates in Omics Studies.
Article in Proteomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- OmixLitMiner 2: Guided Literature Mining for Automated Categorization of Marker Candidates in Omics Studies.Proteomics · 2025Article
- Proteomic Landscape of Colorectal Cancer Derived Liver Metastasis Reveals Three Distinct Phenotypes With Specific Signaling and Enhanced Survival.Molecular & cellular proteomics : MCP · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Omics analyses are crucial for understanding molecular mechanisms in biological research. The vast quantity of detected biomolecules presents a significant challenge in identifying potential biomarkers. Traditional methods rely on labor-intensive literature mining to extract meaningful insights from long lists of regulated candidates of biomolecules. To address this, we developed OmixLitMiner 2 (OLM2) to improve the efficiency of omics data interpretation, speed up the validation of results and accelerate further evaluation based on the selection of marker candidates for subsequent experiments. The updated tool utilizes UniProt for synonym and protein name retrieval and employs the PubMed database as well as PubTator 3.0 for searching titles or abstracts of available biomedical literature. It allows for advanced keyword-based searches and provides classification of proteins or genes with respect to their representation in the literature in relation to scientific questions. OLM2 offers improved functionality over the previous version and comes with a user-friendly Google Colab interface. In comparison to the previous version, OLM2 improves the retrieval of relevant publications and the classification of biomolecules. We use a case study of spatially resolved proteomic data from the mouse brain cortex to demonstrate that the tool significantly reduces the time compared to manual searches and enhances the interpretability of molecular analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.